FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to using a compound of formula
or any of its pharmaceutically acceptable salts, wherein means an aromatic ring, wherein V represents C or N, and when V represents N, V is found in meta- or para-position to Z, R independently represents a hydrogen atom, halogen atom or group specified in -CN group, hydroxyl group, -COOR1 group, (C1-C3)fluoralkyl group, (C1-C3)fluoralkoxy group, -NO2 group, -NR1R2 group, (C1-C4)alkoxy group, phenoxy group and (C1-C3)alkyl group, wherein the above alkyl is optionally monosubstituted by a hydroxyl group, R1 and R2 independently represent a hydrogen atom or (C1-C3)alkyl group, n is equal to 1, 2 or 3, n′ is equal to 1 or 2, R′ represents a hydrogen atom, halogen atom or group specified in (C1-C3)alkyl group, -NO2 group, -NR1R2 group, morpholinyl group, N-methylpiperazinyl group, (C1-C3)fluoralkyl group and (C1-C4)alkoxy group, R″ represents a hydrogen atom, Z, Y, X, W, T and U represent N or C, and wherein at most four of V, T, U, Z, Y, X and W groups represent N, and at least one of T, U, Y, X and W groups represents N, for producing a medicinal preparation for preventing, inhibiting or treating AIDS. The invention also refers to using specific compounds, new quinoline derivatives, a pharmaceutical composition based on the new quinoline derivatives.
EFFECT: new quinoline derivatives are produced, and new biological activity of known compounds is stated.
15 cl, 2 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOUNDS APPLICABLE FOR TREATING PREMATURE AGEING AND PARTICULARLY PROGERIA | 2010 |
|
RU2575646C2 |
COMPOUNDS SUITABLE FOR CANCER TREATMENT | 2010 |
|
RU2567752C2 |
QUINOLINE-2-AMINE DERIVATIVES, USEFUL FOR TREATING AIDS | 2011 |
|
RU2598845C2 |
QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES | 2015 |
|
RU2760686C2 |
PHENYL-N-QUINOLINE DERIVATIVES FOR TREATMENT OF RNA VIRAL INFECTION | 2019 |
|
RU2805064C2 |
COMPOUNDS USEFUL FOR TREATING DISEASES CAUSED BY RETROVIRUSES | 2014 |
|
RU2681943C9 |
ARGINASE INHIBITORS AND THERAPEUTIC USE THEREOF | 2011 |
|
RU2586219C2 |
CALPAIN MODULATORS AND THEIR THERAPEUTIC USE | 2017 |
|
RU2773288C2 |
MULTIFUNCTIONAL QUINOLINE DERIVATIVES AS ANTINEURODEGENERATIVE AGENTS | 2013 |
|
RU2642466C2 |
COMPOSITIONS, SYNTHESIS AND METHODS FOR APPLICATION OF PHENYLCYCLOALKYLMETHYLAMINE DERIVATIVES | 2012 |
|
RU2642074C2 |
Authors
Dates
2016-02-20—Published
2010-06-14—Filed